- Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.
Donald Trump instructed the FDA to accelerate the drug review process.
10 reports, 5 independent
Updated Aug 29
Gone quiet
- Reports
- 10
- Developments
- 1
- Repetition
- 90%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Donald Trump instructed the FDA to accelerate the drug review process.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
Related events
- FDA rule changes are causing delays in product approval, leading to the process exceeding Congressional mandated timeframes.
- FDA is reviewing a new sunscreen ingredient while NPR reports on Donald Trump's political tensions.
- The FDA is facing public scrutiny due to oversight failures, leading to the introduction of new legislation targeting agency shortcomings.
- Fox News reports on agency actions and challenges as the FDA nominee faces confirmation hearing pressure.
- Trump administration slashes food safety enforcement and reduces workforce at FDA, FSIS, and CDC.
Coverage
Newest first; wire copies grouped- newrepublic.com
- healthimpactnews.com
- themirror.com'Devoted' Natalie Harp's 'child and caregiver bond' with Donald Trump exposed
- fda.gov
- fda.gov
- reason.com